Boundless Bio, Inc. (BOLD)

Boundless Bio Statistics

Total Valuation

Boundless Bio has a market cap or net worth of $33.63 million. The enterprise value is -$10.93 million.

Market Cap	33.63M
Enterprise Value	-10.93M

Important Dates

The last earnings date was Friday, May 8, 2026, before market open.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

Boundless Bio has 22.42 million shares outstanding. The number of shares has increased by 0.64% in one year.

Current Share Class	22.42M
Shares Outstanding	22.42M
Shares Change (YoY)	+0.64%
Shares Change (QoQ)	+0.86%
Owned by Insiders (%)	1.72%
Owned by Institutions (%)	38.38%
Float	15.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.39
P/TBV Ratio	0.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.87, with a Debt / Equity ratio of 0.56.

Current Ratio	9.87
Quick Ratio	9.69
Debt / Equity	0.56
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -50.22% and return on invested capital (ROIC) is -23.72%.

Return on Equity (ROE)	-50.22%
Return on Assets (ROA)	-22.83%
Return on Invested Capital (ROIC)	-23.72%
Return on Capital Employed (ROCE)	-46.19%
Weighted Average Cost of Capital (WACC)	3.89%
Revenue Per Employee	n/a
Profits Per Employee	-$2.00M
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.17% in the last 52 weeks. The beta is 0.95, so Boundless Bio's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	+4.17%
50-Day Moving Average	1.31
200-Day Moving Average	1.23
Relative Strength Index (RSI)	54.68
Average Volume (20 Days)	180,714

Short Selling Information

The latest short interest is 145,151, so 0.65% of the outstanding shares have been sold short.

Short Interest	145,151
Short Previous Month	15,345
Short % of Shares Out	0.65%
Short % of Float	0.95%
Short Ratio (days to cover)	0.36

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-60.69M
Pretax Income	-55.99M
Net Income	-55.99M
EBITDA	-59.47M
EBIT	-60.69M
Earnings Per Share (EPS)	-$2.50

Balance Sheet

The company has $92.85 million in cash and $48.29 million in debt, with a net cash position of $44.56 million or $1.99 per share.

Cash & Cash Equivalents	92.85M
Total Debt	48.29M
Net Cash	44.56M
Net Cash Per Share	$1.99
Equity (Book Value)	86.38M
Book Value Per Share	3.86
Working Capital	85.03M

Cash Flow

In the last 12 months, operating cash flow was -$47.10 million and capital expenditures -$495,000, giving a free cash flow of -$47.60 million.

Operating Cash Flow	-47.10M
Capital Expenditures	-495,000
Depreciation & Amortization	1.22M
Net Borrowing	n/a
Free Cash Flow	-47.60M
FCF Per Share	-$2.12

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Boundless Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.64%
Shareholder Yield	-0.64%
Earnings Yield	-166.52%
FCF Yield	-141.55%

Analyst Forecast

The average price target for Boundless Bio is $4.00, which is 166.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.00
Price Target Difference	166.67%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-11.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1